ONCOSEC MEDICAL Inc (ONCS) [Rocket]

In millions, except per share items	Jul-31-22	Jul-31-21	Jul-31-20	Jul-31-19	Jul-31-18	Jul-31-17	Jul-31-16	Jul-31-15
	S-1/A	10-K	10-K	10-K	10-K/A	10-K	10-K	10-K
Revenues [+]	0.0	0.0	0.0	0.0	-0.9	0.0	0.0	0.0
Royalties								13.1
Revenue growth			-100.0%	-99.9%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	-0.9	0.0	0.0	0.0
Gross margin				100.0%	100.0%
Selling, general and administrative [+]	11.2	14.3	18.3	12.0	18.7	9.7	14.7	8.1
General and administrative	11.2	14.3	18.3	12.0	18.7	9.7		8.1
Research and development	25.8	34.1	25.1	18.4	17.4	12.0	14.7	13.1
Other operating expenses							-29.5
EBITDA [+]	-36.8	-48.1	-43.2	-30.2	-36.6	-21.2	0.4	-20.6
EBITDA growth	-23.7%	11.5%	43.1%	-17.7%	72.5%	-6073.9%	-101.7%	84.2%
EBITDA margin				4292129.3%	4187.6%
Depreciation	0.2	0.1	0.2	0.2	0.3	0.4	0.4	0.7
EBITA	-36.9	-48.3	-43.4	-30.4	-37.0	-21.6	0.0	-21.2
EBITA margin				4326796.7%	4225.9%
Amortization of intangibles	0.1	0.1
EBIT [+]	-37.0	-48.4	-43.4	-30.4	-37.0	-21.6	0.0	-21.2
EBIT growth	-23.5%	11.5%	42.7%	-17.7%	71.0%		-100.0%	77.8%
EBIT margin				4326796.7%	4225.9%
Non-recurring items [+]				0.0	-0.9
Loss (gain) on sale of assets				0.0	-0.9
Interest expense	0.0	0.0	0.0	0.0
Interest expense	0.0	0.0	0.0	0.0
Other income (expense), net [+]	-0.5	0.8	0.3	0.1	-3.0	0.2	-26.9
Realized gain (loss) on investments				0.0
Gain (loss) on debt retirement		1.0
Gain (loss) on foreign currency transactions	-0.5	-0.1	0.1	-0.3	-0.1
Other	0.0	0.0	0.2
Pre-tax income	-37.5	-47.6	-43.1	-30.3	-39.1	-21.4	-26.9	-21.2
Income taxes	-3.3	-2.4	-0.9	0.0	0.0	0.0	0.0	0.0
Tax rate	8.9%	5.1%	2.0%
Net income	-34.2	-45.2	-42.3	-30.3	-39.1	-21.4	-26.9	-21.2
Net margin				4306693.2%	4472.2%

Basic EPS [+]	($19.13)	($1.37)	($2.56)	($4.29)	($9.75)	($1.06)	($1.63)	($1.67)
Growth	1293.7%	-46.3%	-40.5%	-56.0%	818.1%	-34.7%	-2.6%	32.6%
Diluted EPS [+]	($19.13)	($1.37)	($2.56)	($4.29)	($9.75)	($1.06)	($1.63)	($1.67)
Growth	1293.7%	-46.3%	-40.5%	-56.0%	818.1%	-34.7%	-2.6%	32.6%

Shares outstanding (basic) [+]	1.8	32.9	16.5	7.1	4.0	20.2	16.5	12.7
Growth	-94.6%	99.0%	134.4%	75.8%	-80.1%	22.3%	29.9%	33.4%
Shares outstanding (diluted) [+]	1.8	32.9	16.5	7.1	4.0	20.2	16.5	12.7
Growth	-94.6%	99.0%	134.4%	75.8%	-80.1%	22.3%	29.9%	33.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.